Saturday, November 21, 2009
Print Current Session:
|
|
Saturday
SESSION XXXI:
THE FUTURE, ISSUES, CONCEPTS AND INTERACTION WITH GOVERNMENT (5-MINUTE TALKS)
Moderators:Robert B. Rutherford, MD / Luis A. Sanchez, MD
|
|
SESSION XXXI SCHEDULE | |
9:52 AM - 9:57 AM | A Look To The Future Of Vascular Disease Treatment |
Presenters(s):Edward B. Diethrich, MD | |
9:58 AM - 10:03 AM | New Products For Improved Endografting From Cook: Is There Anything For Type A Aortic Dissection? |
Presenters(s):Matthew M. Thompson, MD | |
10:04 AM - 10:09 AM | Next Generation Devices For TEVAR: What’s In The Pipeline? |
Presenters(s):Mark A. Farber, MD | |
10:10 AM - 10:15 AM | Why Are Drug Eluting Balloons Going To Work? |
Presenters(s):Lindsay Machan, MD | |
10:16 AM - 10:21 AM | Burning Bridges With Endovascular Treatment: Does Aggressive Endovascular Therapy Lead To More Costly And Inferior Results For Some Patients: How Can We Be More Selective? |
Presenters(s):Michael C. Stoner, MD | |
10:22 AM - 10:27 AM | Increasing Mortality With Decreasing Number Of Patients Treated In A Given Hospital: Should There Be More Regionalization: Will It Decrease Costs? |
Presenters(s):Gilbert R. Upchurch, MD | |
10:28 AM - 10:33 AM | Debate 17: Regulatory Procedures Are Necessary To Protect Patient Safety Even If They Inhibit Innovation Somewhat: The Status Quo In The U.S. Is Good |
Presenters(s):Dorothy B. Abel, BSBME | |
10:34 AM - 10:39 AM | Debate 17: Regulatory Procedures Inhibit Innovation Greatly And The Status Quo With Them In The U.S. Is Bad |
Presenters(s):Thomas J. Fogarty, MD | |
10:40 AM - 10:45 AM | What Will Be The Toll Of U.S. Government Actions On The Device Industry And The Economy: Will We Outsource This Industry Too? |
Presenters(s):Michael H. Wholey, MD, MBA | |
10:46 AM - 10:52 AM | Panel Discussion |
END OF SESSION XXXI | |
previous | next |